Dose-escalation models for combination phase I trials in oncology
To access this article, please choose from the options below
PII: S0959-8049(10)00659-3
doi:10.1016/j.ejca.2010.07.002
© 2010 Elsevier Ltd. All rights reserved.
PII: S0959-8049(10)00659-3
doi:10.1016/j.ejca.2010.07.002
© 2010 Elsevier Ltd. All rights reserved.